Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra Koch

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
United European Gastroenterology Journal|March 28, 2020
Validation of prognostic accuracy of MESH, HKLC, and BCLC classifications in a large German cohort of hepatocellular carcinoma patientsSophia Heinrich, Martin Sprinzl, Irene Schmidtmann, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 22, 2019
Treatment with metformin is associated with a prolonged survival in patients with hepatocellular carcinomaLena Schulte, Bernhard Scheiner, Torsten Voigtländer, et al.
BMC Cancer|February 14, 2016
Organic Cation Transporter 1 (OCT1) mRNA expression in hepatocellular carcinoma as a biomarker for sorafenib treatmentDaniel Grimm, Jonas Lieb, Veronika Weyer, et al.
Journal of Clinical Gastroenterology|September 19, 2013
Trends in epidemiology, treatment, and survival of hepatocellular carcinoma patients between 1998 and 2009: an analysis of 1066 cases of a German HCC RegistryArndt Weinmann, Sandra Koch, Ina M Niederle, et al.
Scandinavian Journal of Gastroenterology|April 5, 2012
Prognostic factors and outcomes of patients with hepatocellular carcinoma in non-cirrhotic liverMarcus A Wörns, Timon Bosslet, Anja Victor, et al.
United European Gastroenterology Journal|March 12, 2021
High pretreatment static and dynamic alpha-fetoprotein values predict reduced overall survival in hepatocellular carcinomaCarolin Czauderna, Irene Schmidtmann, Sandra Koch, et al.
European Journal of Gastroenterology & Hepatology|November 15, 2019
Sarcopenia as prognostic factor for survival after orthotopic liver transplantationDaniel Pinto Dos Santos, Roman Kloeckner, Sandra Koch, et al.
United European Gastroenterology Journal|November 23, 2020
High pre-treatment static and dynamic alpha-fetoprotein values predict reduced overall survival in hepatocellular carcinomaCarolin Czauderna, Irene Schmidtmann, Sandra Koch, et al.
Liver Cancer|November 27, 2019
Improved Prediction of Survival by a Risk Factor-Integrating Inflammatory Score in Sorafenib-Treated Hepatocellular CarcinomaMartin F Sprinzl, Martha M Kirstein, Sandra Koch, et al.
Plos Biology|November 4, 2021
Assembly of infectious Kaposi's sarcoma-associated herpesvirus progeny requires formation of a pORF19 pentamerPeter Naniima, Eleonora Naimo, Sandra Koch, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
United European Gastroenterology Journal|March 28, 2020
Validation of prognostic accuracy of MESH, HKLC, and BCLC classifications in a large German cohort of hepatocellular carcinoma patientsSophia Heinrich, Martin Sprinzl, Irene Schmidtmann, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 22, 2019
Treatment with metformin is associated with a prolonged survival in patients with hepatocellular carcinomaLena Schulte, Bernhard Scheiner, Torsten Voigtländer, et al.
BMC Cancer|February 14, 2016
Organic Cation Transporter 1 (OCT1) mRNA expression in hepatocellular carcinoma as a biomarker for sorafenib treatmentDaniel Grimm, Jonas Lieb, Veronika Weyer, et al.
Journal of Clinical Gastroenterology|September 19, 2013
Trends in epidemiology, treatment, and survival of hepatocellular carcinoma patients between 1998 and 2009: an analysis of 1066 cases of a German HCC RegistryArndt Weinmann, Sandra Koch, Ina M Niederle, et al.
Scandinavian Journal of Gastroenterology|April 5, 2012
Prognostic factors and outcomes of patients with hepatocellular carcinoma in non-cirrhotic liverMarcus A Wörns, Timon Bosslet, Anja Victor, et al.
United European Gastroenterology Journal|March 12, 2021
High pretreatment static and dynamic alpha-fetoprotein values predict reduced overall survival in hepatocellular carcinomaCarolin Czauderna, Irene Schmidtmann, Sandra Koch, et al.
European Journal of Gastroenterology & Hepatology|November 15, 2019
Sarcopenia as prognostic factor for survival after orthotopic liver transplantationDaniel Pinto Dos Santos, Roman Kloeckner, Sandra Koch, et al.
United European Gastroenterology Journal|November 23, 2020
High pre-treatment static and dynamic alpha-fetoprotein values predict reduced overall survival in hepatocellular carcinomaCarolin Czauderna, Irene Schmidtmann, Sandra Koch, et al.
Liver Cancer|November 27, 2019
Improved Prediction of Survival by a Risk Factor-Integrating Inflammatory Score in Sorafenib-Treated Hepatocellular CarcinomaMartin F Sprinzl, Martha M Kirstein, Sandra Koch, et al.
Plos Biology|November 4, 2021
Assembly of infectious Kaposi's sarcoma-associated herpesvirus progeny requires formation of a pORF19 pentamerPeter Naniima, Eleonora Naimo, Sandra Koch, et al.
Pageof 5